Can a single model explain both breast cancer and prostate cancer?

被引:12
|
作者
Friedman, A. Edward [1 ]
机构
[1] Univ Chicago, Dept Math, Chicago, IL 60637 USA
关键词
D O I
10.1186/1742-4682-4-28
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background: The Estradiol-Dihydrotestosterone model of prostate cancer (PC) showed how the interaction of hormones with specific hormone receptors affected apoptosis. The same hormone can produce different effects, depending on which hormone receptor it interacts with. Model: This model proposes that the first step in the development of most PC and breast cancer (BC) occurs when aromatase converts testosterone to estradiol (E2). A sufficiently high enough local level of E2 results in telomerase activity. The telomerase activity allows cell division and may lead to BC or PC, which will proliferate if the rate of cell division is greater than the rate of cell death. The effect of hormones on their hormone receptors will affect the rate of cell death and determine whether or not the cancer proliferates. Conclusion: By minimizing bcl-2 and maximizing apoptotic proteins, new systemic treatments for BC and PC can be developed that may be more effective than existing treatments.
引用
收藏
页数:13
相关论文
共 50 条
  • [1] Can differences in breast cancer utilities explain disparities in breast cancer care?
    Mark D. Schleinitz
    Dina DePalo
    Jeffrey Blume
    Michael Stein
    Journal of General Internal Medicine, 2006, 21 : 1253 - 1260
  • [2] Can differences in breast cancer utilities explain disparities in breast cancer care?
    Schleinitz, Mark D.
    DePalo, Dina
    Blume, Jeffrey
    Stein, Michael
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2006, 21 (12) : 1253 - 1260
  • [3] Ganglionic threat in breast cancer: a model for the prostate cancer?
    Culine, Stephane
    PROGRES EN UROLOGIE, 2006, 16 (02): : 241 - 242
  • [4] Prostate cancer is not breast cancer
    Venniyoor, Ajit
    INDIAN JOURNAL OF MEDICAL AND PAEDIATRIC ONCOLOGY, 2016, 37 (01) : 4 - +
  • [5] Breast cancer by proxy: can the microenvironment be both the cause and consequence?
    Ronnov-Jessen, Lone
    Bissell, Mina J.
    TRENDS IN MOLECULAR MEDICINE, 2009, 15 (01) : 5 - 13
  • [6] Germline mutations in E-cadherin do not explain association of hereditary prostate cancer, gastric cancer and breast cancer
    Jonsson, BA
    Bergh, A
    Stattin, P
    Emmanuelsson, M
    Grönberg, H
    INTERNATIONAL JOURNAL OF CANCER, 2002, 98 (06) : 838 - 843
  • [7] Breast and prostate cancer in the relatives of men with prostate cancer
    McCahy, PJ
    Harris, CA
    Neal, DE
    BRITISH JOURNAL OF UROLOGY, 1996, 78 (04): : 552 - 556
  • [8] Crowdfunding for prostate cancer and breast cancer
    Loeb, Stacy
    Taneja, Sorab
    Walter, Dawn
    Zweifach, Sarah
    Byrne, Nataliya
    BJU INTERNATIONAL, 2018, 122 (05) : 723 - 725
  • [9] Breast and prostate cancer
    B. K. Sharma
    A. Ray
    Indian Journal of Clinical Biochemistry, 2000, 15 (Suppl 1) : 110 - 117
  • [10] Protease Expression Levels in Prostate Cancer Tissue Can Explain Prostate Cancer-Associated Seminal Biomarkers-An Explorative Concept Study
    Neuhaus, Jochen
    Schiffer, Eric
    Mannello, Ferdinando
    Horn, Lars-Christian
    Ganzer, Roman
    Stolzenburg, Jens-Uwe
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2017, 18 (05)